BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jia W, Liang S, Cheng B, Ling C. The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment. Front Oncol 2021;11:763519. [PMID: 34868982 DOI: 10.3389/fonc.2021.763519] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Han H, Wang L, Wang W, Yang M, Qin Y. Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.988956] [Reference Citation Analysis]
2 Peng H, Zhu E, Wang J, Du X, Wang C, Yang M, Zhang Y. RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma. Front Pharmacol 2022;13:989655. [DOI: 10.3389/fphar.2022.989655] [Reference Citation Analysis]
3 Song N, Wang J, Lai Z, Liang S, Zou W, Wang J, Zheng D, Li Y, He Y, Cheng J, Wu Y. Arisaema heterophyllum Blume Monomer Stigmasterol Targets PPARγ and Inhibits the Viability and Tumorigenicity of Lung Adenocarcinoma Cells NCI-H1975. Evid Based Complement Alternat Med 2022;2022:5377690. [PMID: 35911149 DOI: 10.1155/2022/5377690] [Reference Citation Analysis]
4 Yu B, Wang M, Xu H, Gao R, Zhu Y, Ning H, Dai X, Silvestre S. Investigating the Role of Dahuang in Hepatoma Treatment Using Network Pharmacology, Molecular Docking, and Survival Analysis. BioMed Research International 2022;2022:1-15. [DOI: 10.1155/2022/5975223] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Peng H, Du X, Zhang Y. RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma. Front Mol Biosci 2022;9:898567. [DOI: 10.3389/fmolb.2022.898567] [Reference Citation Analysis]